194 related articles for article (PubMed ID: 30323591)
1. Promoting vascular healing using nanofibrous ticagrelor-eluting stents.
Lee CH; Hsieh MJ; Liu KS; Cheng CW; Chang SH; Liu SJ; Wang CJ; Hsu MY; Hung KC; Yeh YH; Chen WJ; Hsieh IC; Juang JH; Wen MS
Int J Nanomedicine; 2018; 13():6039-6048. PubMed ID: 30323591
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stents.
Lee CH; Chang SH; Lin YH; Liu SJ; Wang CJ; Hsu MY; Hung KC; Yeh YH; Chen WJ; Hsieh IC; Wen MS
Biomaterials; 2014 May; 35(15):4417-27. PubMed ID: 24582553
[TBL] [Abstract][Full Text] [Related]
3. Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo.
Lee CH; Hsieh MJ; Chang SH; Hung KC; Wang CJ; Hsu MY; Juang JH; Hsieh IC; Wen MS; Liu SJ
Int J Nanomedicine; 2019; 14():7503-7513. PubMed ID: 31686818
[TBL] [Abstract][Full Text] [Related]
4. Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery.
Lee CH; Lin YH; Chang SH; Tai CD; Liu SJ; Chu Y; Wang CJ; Hsu MY; Chang H; Chang GJ; Hung KC; Hsieh MJ; Lin FC; Hsieh IC; Wen MS; Huang Y
Int J Nanomedicine; 2014; 9():311-26. PubMed ID: 24421640
[TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury.
Chang SH; Lee CH; Yeh YH; Liu SJ; Wang CJ; Hsu MY; Chen WJ
Int J Nanomedicine; 2018; 13():1761-1771. PubMed ID: 29606869
[TBL] [Abstract][Full Text] [Related]
6. Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.
Lee CH; Yu CY; Chang SH; Hung KC; Liu SJ; Wang CJ; Hsu MY; Hsieh IC; Chen WJ; Ko YS; Wen MS
Int J Nanomedicine; 2014; 9():4117-33. PubMed ID: 25206303
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning.
Janjic M; Pappa F; Karagkiozaki V; Gitas C; Ktenidis K; Logothetidis S
Int J Nanomedicine; 2017; 12():6343-6355. PubMed ID: 28919738
[TBL] [Abstract][Full Text] [Related]
8. Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model.
Kim HK; Jeong MH; Lim KS; Kim JH; Lim HC; Kim MC; Hong YJ; Kim SS; Park KH; Chang KS
Int J Cardiol; 2017 Aug; 240():326-331. PubMed ID: 28487152
[TBL] [Abstract][Full Text] [Related]
9. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
Cho HJ; Kim TY; Cho HJ; Park KW; Zhang SY; Kim JH; Kim SH; Hahn JY; Kang HJ; Park YB; Kim HS
J Am Coll Cardiol; 2006 Jul; 48(2):366-74. PubMed ID: 16843188
[TBL] [Abstract][Full Text] [Related]
10. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
11. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
Trials; 2012 May; 13():55. PubMed ID: 22559260
[TBL] [Abstract][Full Text] [Related]
12. Sustained local delivery of high-concentration vancomycin from a hybrid biodegradable, antibiotic-eluting, nanofiber-loaded endovascular prosthesis for treatment of mycotic aortic aneurysms.
Liu KS; Lee CH; Lee D; Liu M; Tsai FC; Tseng YY
J Vasc Surg; 2018 Aug; 68(2):597-606. PubMed ID: 29066243
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
Mori H; Cheng Q; Lutter C; Smith S; Guo L; Kutyna M; Torii S; Harari E; Acampado E; Joner M; Kolodgie FD; Virmani R; Finn AV
JACC Cardiovasc Interv; 2017 Dec; 10(23):2375-2387. PubMed ID: 29102583
[TBL] [Abstract][Full Text] [Related]
15. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
17. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
Douglas G; Van Kampen E; Hale AB; McNeill E; Patel J; Crabtree MJ; Ali Z; Hoerr RA; Alp NJ; Channon KM
Eur Heart J; 2013 Nov; 34(43):3378-88. PubMed ID: 23008511
[TBL] [Abstract][Full Text] [Related]
19. Exosome-eluting stents for vascular healing after ischaemic injury.
Hu S; Li Z; Shen D; Zhu D; Huang K; Su T; Dinh PU; Cores J; Cheng K
Nat Biomed Eng; 2021 Oct; 5(10):1174-1188. PubMed ID: 33820981
[TBL] [Abstract][Full Text] [Related]
20. Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent.
Zhao Y; Du R; Zhou T; Yang D; Huang Y; Wang Y; Huang J; Ma X; He F; Qiu J; Wang G
Adv Healthc Mater; 2018 Aug; 7(15):e1800207. PubMed ID: 29770610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
